Published March 10, 2021 | Version v1
Book chapter Open

African swine fever vaccines

  • 1. The Pirbright Institute

Description

Review of African swine fever virus vaccines as of 2021

African swine fever virus causes an acute haemorrhagic fever in domestic pigs and wild boar
which is invariably fatal. Introduction of the disease into Georgia in 2007 has led to the deaths
of tens of millions of animals across Eastern Europe, Asia and Oceania with serious effects on
animal welfare and global food security. Control of the disease is impaired by the lack of an
effective vaccine and is dependent on strict biosecurity at the farm gate, and rapid diagnosis,
quarantine and slaughter of infected herds. The few pigs that do recover from disease are robustly
protected from a subsequent encounter with the same virus isolate, showing that immunity is
achievable. This review provides a historical perspective on the approaches that researchers have
taken to develop African swine fever vaccines, as well as discussing promising modern techniques
such as targeted gene deleted viruses and viral vectored vaccines.

Files

978-90-8686-910-7_6.pdf

Files (413.3 kB)

Name Size Download all
md5:d31f1b13d3853e8683cd2e113e09ff25
413.3 kB Preview Download

Additional details

Funding

High Containment BBS/E/I/00007037
UK Research and Innovation
Disease Pathogenesis BBS/E/I/00007030
UK Research and Innovation
Recognition and control of virus infections BBS/E/I/00007031
UK Research and Innovation
Science Services BBS/E/I/00007039
UK Research and Innovation
DEFEND – Addressing the dual emerging threats of African Swine Fever and Lumpy Skin Disease in Europe (DEFEND) 773701
European Commission
Studentship: Autophagy and African swine fever virus BBS/E/I/00002120
UK Research and Innovation